Dr. Nicholas Butowski, MD
Claim this profileUniversity of California San Francisco
Expert in Solid Tumors
Expert in Glioblastoma
16 reported clinical trials
33 drugs studied
Area of expertise
1Solid Tumors
Global LeaderStage III
Stage IV
IDH positive
2Glioblastoma
Global LeaderIDH positive
MET positive
MGMT
Affiliated Hospitals
Clinical Trials Nicholas Butowski, MD is currently running
Multiple Therapies
for Glioblastoma
This trial is testing various treatments for patients with newly diagnosed or returning brain cancer. It adjusts treatments based on how well patients are doing to find the most effective options. The goal is to improve survival rates by matching the best treatments to specific patient types.
Recruiting1 award Phase 2 & 310 criteria
Keto Diet vs Standard Cancer Diet
for Glioblastoma
This is a Phase 2, randomized two-armed, multi-site study of 170 patients with newly diagnosed glioblastoma multiforme. Patients will be randomized 1:1 to receive Keto Diet, or Standard Anti-Cancer Diet. All patients will receive standard of care treatment for their glioblastoma. The Keto Diet intervention will be for an 18-week period and conducted by trained research dietitians. Daily ketone and glucose levels will be recorded to monitor Keto Diet adherence. This two-armed randomized multi-site study aims to provide evidence to support the hypothesis that a Keto Diet vs. Standard Anti-Cancer Diet improves overall survival in newly diagnosed glioblastoma multiforme patients who receive standard of care treatment.
Recruiting0 awards Phase 2
More about Nicholas Butowski, MD
Clinical Trial Related7 years of experience running clinical trials · Led 16 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Nicholas Butowski, MD has experience with
- ONC201
- Lomustine
- Temozolomide
- SONALA-001 And Exablate 4000 Type 2
- Optune®
- RMC-5552
Breakdown of trials Nicholas Butowski, MD has run
Solid Tumors
Glioblastoma
Relapse
Brain Tumor
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Nicholas Butowski, MD specialize in?
Nicholas Butowski, MD focuses on Solid Tumors and Glioblastoma. In particular, much of their work with Solid Tumors has involved Stage III patients, or patients who are Stage IV.
Is Nicholas Butowski, MD currently recruiting for clinical trials?
Yes, Nicholas Butowski, MD is currently recruiting for 6 clinical trials in San Francisco California. If you're interested in participating, you should apply.
Are there any treatments that Nicholas Butowski, MD has studied deeply?
Yes, Nicholas Butowski, MD has studied treatments such as ONC201, Lomustine, Temozolomide.
What is the best way to schedule an appointment with Nicholas Butowski, MD?
Apply for one of the trials that Nicholas Butowski, MD is conducting.
What is the office address of Nicholas Butowski, MD?
The office of Nicholas Butowski, MD is located at: University of California San Francisco, San Francisco, California 94143 United States. This is the address for their practice at the University of California San Francisco.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.